(Q30470952)

21 June 2017

title

Cisapride in the long-term treatment of chronic gastroparesis: a 2-year open-label study (English)

1 reference

21 June 2017

1 reference

1 reference

B J Kendall

1

1 reference

21 June 2017

E T Kendall

series ordinal

2

1 reference

21 June 2017

I Soykan

series ordinal

3

1 reference

21 June 2017

R W McCallum

series ordinal

4

1 reference

21 June 2017

publication date

1 July 1997

1 reference

Journal of International Medical Research

21 June 2017

published in

1 reference

21 June 2017

volume

25

1 reference

21 June 2017

issue

4

1 reference

21 June 2017

page(s)

182-189

1 reference

Cisapride stimulates antral motility and decreases biliary reflux in patients with severe dyspepsia.

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F030006059702500402

Longterm oral cisapride improves interdigestive antroduodenal motility in dyspeptic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059702500402

Objective and subjective results of a randomized, double-blind, placebo-controlled trial using cisapride to treat gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059702500402

Effect of chronic administration of cisapride on gastric emptying of a solid meal and on dyspeptic symptoms in patients with idiopathic gastroparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059702500402

Long-term efficacy of oral cisapride in symptomatic upper gut dysmotility.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F030006059702500402

10.1177/030006059702500402

21 January 2018

Identifiers

DOI

1 reference

21 June 2017

1 reference